Apollomics (APLM) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $21.00, -3.54% vs the prior close of $21.77.
- Volume 7.40K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
APLM slides 3.5% to $21.00, a 1-month low. Closed at $21.00, -3.54% vs the prior close of $21.77. Day range $21.00–$22.62, opened at $21.81.
APLM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — APLM slides 3.5% to $21.00, a 1-month low
- Closed at $21.00, -3.54% vs the prior close of $21.77. Day range $21.00–$22.62, opened at $21.81.
- Volume was 7.40K shares, 0.4x its 50-day average of 17.39K — lighter than usual.
- Price is -9.2% vs its 50-day average ($23.12) and +11.0% vs its 200-day average ($18.91).
- 52-week range $10.01–$42.12; today's close sits at 34% of that range, 50.1% below the 52-week high.
Oct 14, 2026 — APLM rises 2.1% to $21.77
- Closed at $21.77, +2.11% vs the prior close of $21.32. Day range $21.77–$21.77, opened at $21.77.
- Volume was 2.00K shares, 0.1x its 50-day average of 17.43K — lighter than usual.
- Price is -5.5% vs its 50-day average ($23.04) and +15.1% vs its 200-day average ($18.91).
- 52-week range $10.01–$42.12; today's close sits at 37% of that range, 48.3% below the 52-week high.
Oct 13, 2026 — APLM ends flat (+0.0%) to $21.32, 3 down days in a row
- Closed at $21.32, +0.00% vs the prior close of $21.32. Day range $21.32–$21.32, opened at $21.32.
- Price is -7.1% vs its 50-day average ($22.96) and +12.8% vs its 200-day average ($18.90).
- 52-week range $10.01–$42.12; today's close sits at 35% of that range, 49.4% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — APLM dips 0.8% to $21.32, a 1-month low
- Closed at $21.32, -0.84% vs the prior close of $21.50. Day range $21.17–$21.32, opened at $21.17.
- Volume was 1.70K shares, 0.1x its 50-day average of 17.51K — lighter than usual.
- Price is -6.8% vs its 50-day average ($22.88) and +12.9% vs its 200-day average ($18.89).
- 52-week range $10.01–$42.12; today's close sits at 35% of that range, 49.4% below the 52-week high.
Oct 9, 2026 — APLM dips 1.3% to $21.50
- Closed at $21.50, -1.29% vs the prior close of $21.78. Day range $21.10–$22.50, opened at $21.70.
- Volume was 8.80K shares, 0.5x its 50-day average of 17.40K — lighter than usual.
- Price is -5.7% vs its 50-day average ($22.80) and +14.0% vs its 200-day average ($18.87).
- 52-week range $10.01–$42.12; today's close sits at 36% of that range, 49.0% below the 52-week high.
Oct 8, 2026 — APLM rises 1.3% to $21.78
- Closed at $21.78, +1.30% vs the prior close of $21.50. Day range $21.25–$22.65, opened at $22.65.
- Volume was 6.60K shares, 0.4x its 50-day average of 17.45K — lighter than usual.
- Price is -4.1% vs its 50-day average ($22.71) and +15.5% vs its 200-day average ($18.85).
- 52-week range $10.01–$42.12; today's close sits at 37% of that range, 48.3% below the 52-week high.
Oct 7, 2026 — APLM dips 2.7% to $21.50, a 1-month low, 5 down days in a row
- Closed at $21.50, -2.71% vs the prior close of $22.10. Day range $21.50–$22.25, opened at $21.95.
- Volume was 6.60K shares, 0.4x its 50-day average of 17.44K — lighter than usual.
- Price is -5.0% vs its 50-day average ($22.63) and +14.2% vs its 200-day average ($18.83).
- 52-week range $10.01–$42.12; today's close sits at 36% of that range, 49.0% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — APLM slides 5.0% to $22.10, a 1-month low, 4 down days in a row
- Closed at $22.10, -5.01% vs the prior close of $23.27. Day range $21.90–$23.70, opened at $23.70.
- Volume was 13.20K shares, 0.8x its 50-day average of 17.41K.
- Price is -2.0% vs its 50-day average ($22.56) and +17.6% vs its 200-day average ($18.79).
- 52-week range $10.01–$42.12; today's close sits at 38% of that range, 47.5% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — APLM ends flat (+0.0%) to $23.27, 3 down days in a row
- Closed at $23.27, +0.00% vs the prior close of $23.27. Day range $23.27–$23.27, opened at $23.27.
- Price is +3.5% vs its 50-day average ($22.48) and +24.0% vs its 200-day average ($18.76).
- 52-week range $10.01–$42.12; today's close sits at 41% of that range, 44.8% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — APLM ends flat (+0.0%) to $23.27
- Closed at $23.27, +0.00% vs the prior close of $23.27. Day range $23.27–$23.27, opened at $23.27.
- Price is +4.0% vs its 50-day average ($22.38) and +24.2% vs its 200-day average ($18.73).
- 52-week range $10.01–$42.12; today's close sits at 41% of that range, 44.8% below the 52-week high.
APLM latest news & SEC filings
Every SEC filing by or about APLM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Chen Yi-Kuei converted options/RSUs into 5,000 shares on Sep 15, 2026; now holds 20,100
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Lin Peter Kuan-How converted options/RSUs into 10,000 shares on Sep 15, 2026; now holds 58,979
- Lin Peter Kuan-How had withheld for taxes 3,416 shares at $24.02 (≈$82.05K) on Sep 15, 2026; now holds 55,563
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Yen Hung Hsien converted options/RSUs into 500 shares on Sep 15, 2026; now holds 500
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lin Peter Kuan-How converted options/RSUs into 10,000 shares on Sep 15, 2026; now holds 58,979
- Lin Peter Kuan-How had withheld for taxes 3,416 shares at $24.02 (≈$82.05K) on Sep 15, 2026; now holds 55,563
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chen Hong-Jung converted options/RSUs into 500 shares on Sep 15, 2026; now holds 4,120
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chen Yi-Kuei converted options/RSUs into 5,000 shares on Sep 15, 2026; now holds 20,100
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 17, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade APLM
- How much it moves: over the last 20 sessions the average daily move was 2.41% (largest 6.7%).
- Liquidity: about 7.00K shares (≈$146.90K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $21.00 vs a range of $10.01–$42.12 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:100 on Nov 25, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 5 open-market buys, 0 sales; latest: Hung-Wen Chen bought 266,667 shares on Aug 14, 2026.
- Latest filings: 6-K Aug 12, 2026; 6-K Jul 21, 2026; 6-K Jul 14, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
APLM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 21.81 | 22.62 | 21.00 | 21.00 | 7.40K |
| Oct 14, 2026 | 21.77 | 21.77 | 21.77 | 21.77 | 2.00K |
| Oct 13, 2026 | 21.32 | 21.32 | 21.32 | 21.32 | 0 |
| Oct 12, 2026 | 21.17 | 21.32 | 21.17 | 21.32 | 1.70K |
| Oct 9, 2026 | 21.70 | 22.50 | 21.10 | 21.50 | 8.80K |
| Oct 8, 2026 | 22.65 | 22.65 | 21.25 | 21.78 | 6.60K |
| Oct 7, 2026 | 21.95 | 22.25 | 21.50 | 21.50 | 6.60K |
| Oct 6, 2026 | 23.70 | 23.70 | 21.90 | 22.10 | 13.20K |
| Oct 5, 2026 | 23.27 | 23.27 | 23.27 | 23.27 | 0 |
| Oct 2, 2026 | 23.27 | 23.27 | 23.27 | 23.27 | 0 |
| Oct 1, 2026 | 23.00 | 23.27 | 23.00 | 23.27 | 1.20K |
| Sep 30, 2026 | 24.95 | 24.95 | 24.95 | 24.95 | 1.30K |
| Sep 29, 2026 | 22.18 | 24.67 | 22.18 | 24.12 | 10.10K |
| Sep 28, 2026 | 23.80 | 24.50 | 23.20 | 23.84 | 2.40K |
| Sep 25, 2026 | 24.80 | 24.96 | 22.00 | 22.35 | 39.60K |
| Sep 24, 2026 | 23.48 | 23.48 | 23.48 | 23.48 | 1.30K |
| Sep 23, 2026 | 22.76 | 24.10 | 21.88 | 23.40 | 25.00K |
| Sep 22, 2026 | 25.00 | 25.00 | 22.23 | 23.72 | 3.20K |
| Sep 21, 2026 | 23.96 | 25.00 | 23.91 | 23.91 | 2.80K |
| Sep 18, 2026 | 22.50 | 24.77 | 22.50 | 23.42 | 6.70K |
About Apollomics
Apollomics (APLM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in COVINA, CA. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1944885.
APLM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Hong-Jung Chen | Director | Sep 17, 2026 |
| Yi-An Chu | Director | Jun 16, 2026 |
| Hung-Wen Chen | Chief Executive Officer | Sep 17, 2026 |
| Yi-Kuei Chen | Chief Operating Officer | Sep 24, 2026 |
| Ya-Chi Huang | Director | Sep 17, 2026 |
| Chen-Huan Jan | Director | Jun 16, 2026 |
| Hsien-Shu Tsai | Director | Sep 17, 2026 |
| Hung Hsien Yen | Director | Sep 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hung-Wen Chen | Chief Executive Officer | Sep 17, 2026 |
| Yi-Kuei Chen | Chief Operating Officer | Sep 24, 2026 |
| Peter Kuan-How Lin | Chief Financial Officer | Sep 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2026 | Hung-Wen Chen | Buy | 266,667 | $15.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 166,667 | $12.00 |
| Aug 14, 2026 | Hung-Wen Chen | Buy | 103,333 | $15.00 |
| Aug 14, 2026 | Yi-Kuei Chen | Buy | 20,000 | $15.00 |
| Aug 14, 2026 | Peter Kuan-How Lin | Buy | 26,667 | $15.00 |
APLM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
APLM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on APLM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.